Viewing StudyNCT00072579



Ignite Creation Date: 2024-05-05 @ 11:31 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00072579
Status: COMPLETED
Last Update Posted: 2017-01-19
First Post: 2003-11-04

Brief Title: Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment
Sponsor: Wake Forest University Health Sciences
Organization: Wake Forest University Health Sciences

Organization Data

Organization: Wake Forest University Health Sciences
Class: OTHER
Study ID: CCCWFU-23102
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Wake Forest University Health Sciences
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH